GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (OTCPK:CMPUY) » Definitions » Total Equity

CMPUY (CompuGroup Medical SE KgaA) Total Equity : $679 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is CompuGroup Medical SE KgaA Total Equity?

CompuGroup Medical SE KgaA's total equity for the quarter that ended in Dec. 2024 was $679 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

CompuGroup Medical SE KgaA Total Equity Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Total Equity Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 777.30 691.85 713.80 729.85 678.86

CompuGroup Medical SE KgaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 729.85 750.62 694.20 705.04 678.86

CompuGroup Medical SE KgaA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

CompuGroup Medical SE KgaA's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=2058.289-1379.43
=679

CompuGroup Medical SE KgaA's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=2058.289-1379.43
=679

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CompuGroup Medical SE KgaA Total Equity Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CompuGroup Medical SE KgaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (OTCPK:CMPUY) » Definitions » Total Equity
Comparable Companies
XTER:NXU XTER:AJ91 XTER:M3V VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY SZSE:300253 HKSE:02228 HKSE:02587 BTSG NSE:IKS PRVA NSE:SAGILITY HKSE:01833 HKSE:02506
Traded in Other Exchanges
CMPVF:USA 0MSD:UK COP:Germany COP:Austria
Address
Maria Trost 21, Koblenz, DEU, 56070
Website
https://www.cgm.com
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.